Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 464892017 | Benztropine mesylate 2mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 464893010 | Benzatropine mesylate 2mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 717422017 | Benztropine mesylate 2mg tablet (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 1190056012 | Benztropine mesylate 2mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 1236227014 | Benzatropine mesylate 2mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 1236780012 | Benztropine mesylate 2mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 2154535015 | Benzatropine mesylate 2mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 2155561014 | Benztropine mesylate 2mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 3483965016 | Product containing benzatropine mesylate 2 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3492509011 | Product containing benzatropine mesylate 2 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3492511019 | Product containing benztropine mesylate 2 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3500645018 | Benztropine mesylate 2 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module | 
| 3500646017 | Benzatropine mesylate 2 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3566344012 | Product containing only benztropine mesylate 2 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3566345013 | Product containing only benzatropine mesylate 2 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3566346014 | Product containing only benzatropine mesylate 2 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3677031016 | Product containing precisely benzatropine mesylate 2 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3677032011 | Product containing precisely benzatropine mesylate 2 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3782461018 | Benzatropine mesilate 2 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module | 
| 3782462013 | Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module | 
| 66643801000001113 | Benzatropine 2mg tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Benzatropine mesilate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing benzatropine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Benzatropine mesilate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing benzatropine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Benzatropine mesilate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Benzatropine mesilate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 2 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Benzatropine mesilate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only benzatropine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Benzatropine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Benzatropine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | VMP non-availability indicator | Not available | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has specific active ingredient | Benzatropine mesilate | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | VMP non-availability indicator | Re-introduced | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Benzatropine mesylate 2mg tablet - product | Is a | False | Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Cogentin 2mg tablets (Organon Pharma (UK) Ltd) | Is a | True | Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Benzatropine 2mg tablets 60 tablet | Is pack of | False | Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Benzatropine 2mg tablets 60 tablet | Has VMP | True | Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Benzatropine 2mg tablets (Special Order) | Is a | True | Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Benzatropine 2mg tablets 1 tablet | Has VMP | True | Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | 
This concept is not in any reference sets